| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D, Coo-novitium Ops
1 company
Shanmugam Muthusamy serves as a Head Of R&D, Coo-novitium Ops at ANIP. Across recent SEC filings that breaks down to 2 buys and 60 sells. Those positions are worth an estimated $7.8M at current prices.
Historically, Shanmugam Muthusamy's trades have earned a middling insider score of 59/100 across 61 rated trades. Over a 12-month horizon, 28.1% of those trades were profitable, with an average 12-month return of -4.6%.
The biggest single holding is ANIP (~$7.8M) as Head Of R&D, Coo-novitium Ops. The recent filings there lean toward selling, a net 879,890 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 100,000 | $90.36 | $9,036,007.96 | -18.8% | -11.9% | -17.3% | |
| Aug 15, 2025 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 100,000 | $88.25 | $8,824,533.30 | -15.8% | -3.3% | -12.5% | |
| May 9, 2025 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 700 | $76.83 | $53,781.00 | -0.1% | +4.1% | +23.5% | |
| Jul 18, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 2,743 | $62.00 | $170,066.00 | -0.4% | -2.8% | +8.1% | |
| Jul 17, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 47,257 | $63.73 | $3,011,592.12 | -6.9% | -7.0% | +8.0% | |
| Jun 21, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 20,000 | $58.90 | $1,178,000.00 | -2.8% | +3.2% | +12.0% | |
| Jun 20, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 30,000 | $60.59 | $1,817,662.60 | -4.1% | +2.8% | +10.4% | |
| May 20, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 12,855 | $61.81 | $794,567.55 | -1.7% | -0.8% | -1.8% | |
| May 17, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 37,145 | $64.37 | $2,391,120.80 | -4.7% | -0.5% | -2.3% | |
| Apr 19, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 27,232 | $65.10 | $1,772,729.07 | -3.4% | -6.3% | +3.9% |